CD8A and ovarian carcinoma: Others have observed chemotherapy-dependent CD8+/CD4+ T-cell infiltration in response to paclitaxel and gemcitabine in a murine model of ovarian cancer (74) and 5-FU in a murine model of breast cancer (10).